HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ban-Hock Toh Selected Research

B-Cell Activation Factor Receptor

2/2017Opposing roles of B lymphocyte subsets in atherosclerosis.
1/2013BAFF receptor mAb treatment ameliorates development and progression of atherosclerosis in hyperlipidemic ApoE(-/-) mice.
1/2012Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ban-Hock Toh Research Topics

Disease

21Atherosclerosis
01/2021 - 10/2006
19Autoimmune Diseases (Autoimmune Disease)
11/2017 - 02/2003
11Gastritis
01/2020 - 02/2002
9Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
04/2014 - 08/2008
7Inflammation (Inflammations)
11/2017 - 10/2006
5Myocardial Infarction
01/2021 - 02/2016
4Stroke (Strokes)
01/2021 - 02/2016
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
04/2014 - 11/2006
3Disease Resistance
03/2014 - 02/2003
2Atherosclerotic Plaque (Atheroma)
01/2019 - 03/2013
2Infections
12/2017 - 11/2017
2Autoimmune Hepatitis
05/2017 - 01/2009
2Pernicious Anemia
01/2017 - 09/2002
2Necrosis
02/2016 - 01/2015
2Hypertension (High Blood Pressure)
11/2015 - 01/2014
2Demyelinating Diseases (Demyelinating Disease)
07/2012 - 08/2008
2Multiple Sclerosis
07/2012 - 12/2010
2Body Weight (Weight, Body)
01/2012 - 09/2011
2Neoplasms (Cancer)
10/2011 - 02/2006
1Ischemic Stroke
01/2020
1Sclerosing Cholangitis
05/2017
1Liver Cirrhosis (Hepatic Cirrhosis)
05/2017
1Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
05/2017
1Liver Diseases (Liver Disease)
05/2017
1Rupture
02/2017
1Iron-Deficiency Anemia (Anemia, Iron Deficiency)
01/2017
1Megaloblastic Anemia
01/2017
1Vascular Remodeling
11/2015
1IgG Deficiency
11/2015
1Autoimmune Thyroiditis (Lymphomatous Thyroiditis)
04/2014
1Atrophy
04/2014
1Neuroinflammatory Diseases
07/2012
1Arteritis
01/2012
1Hypersensitivity (Allergy)
10/2011

Drug/Important Bio-Agent (IBA)

15AutoantigensIBA
07/2012 - 02/2003
13Apolipoproteins E (ApoE)IBA
01/2021 - 10/2006
8AntigensIBA
05/2017 - 02/2002
8Myelin-Oligodendrocyte GlycoproteinIBA
04/2014 - 08/2008
7AntibodiesIBA
11/2015 - 03/2002
6ApolipoproteinsIBA
01/2021 - 10/2010
6Immunoglobulin M (IgM)IBA
01/2018 - 09/2011
5Immunoglobulin G (IgG)IBA
01/2021 - 01/2014
5Proteins (Proteins, Gene)FDA Link
01/2021 - 08/2004
5AutoantibodiesIBA
01/2021 - 09/2002
5LipidsIBA
01/2019 - 10/2010
5CytokinesIBA
01/2018 - 10/2011
4Monoclonal AntibodiesIBA
01/2018 - 09/2012
4H(+)-K(+)-Exchanging ATPase (Hydrogen, Potassium ATPase)IBA
01/2017 - 02/2004
4Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
11/2008 - 02/2002
3Immunoglobulins (Immunoglobulin)IBA
01/2021 - 01/2018
3Intrinsic FactorFDA Link
01/2020 - 04/2014
3CholesterolIBA
02/2017 - 10/2006
3B-Cell Activation Factor ReceptorIBA
02/2017 - 01/2012
3PerforinIBA
01/2015 - 03/2013
3Granzymes (Granzyme)IBA
01/2015 - 03/2013
2AcidsIBA
01/2020 - 01/2017
2Actins (F Actin)IBA
05/2017 - 01/2009
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
02/2017 - 02/2016
2oxidized low density lipoproteinIBA
02/2017 - 11/2016
2GastrinsIBA
01/2017 - 04/2014
2InterferonsIBA
01/2015 - 03/2013
2Adenosine Triphosphatases (ATPase)IBA
04/2014 - 09/2002
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2013 - 02/2004
2CollagenIBA
09/2011 - 10/2006
2Glycoproteins (Glycoprotein)IBA
12/2010 - 08/2004
2Telomerase (Telomerase Reverse Transcriptase)IBA
02/2006 - 11/2005
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2021
1AlarminsIBA
01/2021
1Cytotoxins (Cytolysins)IBA
11/2017
1ChemokinesIBA
11/2017
1anti-liver kidney microsome antibody (LKMA)IBA
05/2017
1Antinuclear AntibodiesIBA
05/2017
1Therapeutic UsesIBA
02/2017
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
01/2017
1phosphorylethanolamine (phosphoethanolamine)IBA
02/2016
1tesmilifene (DPPE)IBA
02/2016
1AllergensIBA
02/2016
1Angiotensin IIIBA
11/2015
1Liposomes (Liposome)IBA
06/2015
1PhosphatidylserinesIBA
06/2015
1interleukin-21 (interleukin 21)IBA
01/2015
1Interleukin-4 (Interleukin 4)IBA
01/2015
1Adrenal Cortex Hormones (Corticosteroids)IBA
04/2014
1IronIBA
04/2014
1Biomarkers (Surrogate Marker)IBA
04/2014
1Pepsinogen A (Pepsinogen)IBA
04/2014
1InterleukinsIBA
03/2013
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
03/2013
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
03/2013
1Interleukin-2 (IL2)IBA
09/2012
1Fluorouracil (Carac)FDA LinkGeneric
03/2012
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2011

Therapy/Procedure

6Therapeutics
01/2020 - 10/2011
5Transplantation
08/2011 - 02/2003
2Splenectomy
01/2018 - 06/2015
2Thymectomy
02/2004 - 02/2002
1Immunomodulation
12/2017
1Immunotherapy
11/2017
1Hematopoietic Stem Cell Transplantation
10/2011
1Tissue Transplantation
10/2011